Helicobacter pylorieradication therapy: indications, efficacy and safety
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14740338.7.3.271
Reference86 articles.
1. Editorial: Can Therapy Ever Be Denied for Helicobacter pylori Infection?
2. Helicobacter pylori infection in Finland
3. Prevalence of Helicobacter pylori in Indigenous Western Australians: comparison between urban and remote rural populations
4. Helicobacter pyloriInfection and Dyspepsia
5. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Unlocking Future Research Strategies: Key Collaborations and Network Characteristics in Helicobacter Pylori Eradication Therapy (2000-2023);2024-09-02
2. Helicobacter pylori Eradication Therapy-associated Diarrhea;The Korean Journal of Helicobacter and Upper Gastrointestinal Research;2021-09-10
3. Adverse Event Profile During the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients From the European Registry on H. pylori Management (Hp-EuReg);American Journal of Gastroenterology;2021-04-08
4. Pharmacologic treatment of GERD: Where we are now, and where are we going?;Annals of the New York Academy of Sciences;2020-09-15
5. TRIZ Theory and the Method of Cancer Document Selection for Chemical Complexes and Innovation Schemes of Meta-Analysis with Lymphomas as an Example;Journal of Chemistry;2020-05-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3